Listen now 30 mins
Peter Day visits Washington DC to see whether the regulators will allow an HIV-Aids drug, now called Maraviroc, to reach the marketplace.
This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.